drug

President Donald Trump arrives in the Brady Press Briefing Room at the White House on Jan. 30, 2025 in Washington, DC.Oliver Contreras | Afp | Getty ImagesPresident Donald Trump likely won't do away with a landmark process that allows…

Shana Novak | Stone | Getty ImagesPresident Donald Trump's steep tariffs on Canada, Mexico and China could worsen ex­ist­ing drug shortages in the U.S., raise health-care costs for patients and threaten cash-strapped generic drugmakers,…

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | ReutersThe Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations…

Most Medicare patients who hit the new $2,000 cap on out-of-pocket spending for prescription drugs could see massive savings, despite changes in premiums, according to a report released Thursday by AARP. The findings suggest the cap…

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty ImagesBristol Myers Squibb believes Alzheimer's is the largest…

The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty ImagesEli Lilly cut its revenue guidance on Tuesday as it said demand for its…

Niels Wenstedt | Getty ImagesJohnson & Johnson on Tuesday said its lung cancer regimen keeps people alive for at least a year longer than AstraZeneca's Tagrisso, the go-to drug for a certain type of lung cancer.J&J in a statement…

 GSK will pay $1bn upfront to acquire the Massachussetts-based company IDRx is developing a treatment for gastrointestinal stromal tumours (GIST)By HARRY WISE Updated: 04:21 EST, 13 January 2025 <!-- …

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersCompanies are increasing access to new blockbuster weight-loss drugs for employees, but size of employer…

Biogen has halved the price of its Alzheimer’s drug Aduhelm, after sales fell short of expectations because insurers have been reluctant to pay for the treatment. The Boston-based biotech said it would now charge a list price of $28,200…